These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 3095497

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
    James SL, Skamene E, Meltzer MS.
    J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages.
    James SL.
    J Immunol; 1986 May 15; 136(10):3872-7. PubMed ID: 3084646
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modulation of macrophage activation and resistance by suppressor T lymphocytes in chronic murine Schistosoma mansoni infection.
    Olds GR, Ellner JJ.
    J Immunol; 1984 Nov 15; 133(5):2720-4. PubMed ID: 6237154
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
    Chaiworaporn R, Maneerat Y, Rojekittikhun W, Ramasoota P, Janecharut T, Matsuda H, Kitikoon V.
    Southeast Asian J Trop Med Public Health; 2005 Jul 15; 36(4):846-52. PubMed ID: 16295535
    [Abstract] [Full Text] [Related]

  • 10. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses.
    James SL, Correa-Oliveira R, Leonard EJ.
    J Immunol; 1984 Sep 15; 133(3):1587-93. PubMed ID: 6431002
    [Abstract] [Full Text] [Related]

  • 11. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection.
    James SL, Sher A, Lazdins JK, Meltzer MS.
    J Immunol; 1982 Apr 15; 128(4):1535-40. PubMed ID: 7061842
    [Abstract] [Full Text] [Related]

  • 12. Amphotericin B-induced resistance to Schistosoma mansoni.
    Olds GR, Stewart SJ, Ellner JJ.
    J Immunol; 1981 May 15; 126(5):1667-70. PubMed ID: 7217661
    [Abstract] [Full Text] [Related]

  • 13. Systemic delivery of an adenovirus expressing EBV-derived vIL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: controversial effects on the development of pathological parameters.
    Verwaerde C, Thiam K, Delanoye A, Fernandez-Gomez R, D'Halluin J, Auriault C.
    Eur Cytokine Netw; 1999 Jun 15; 10(2):161-70. PubMed ID: 10400822
    [Abstract] [Full Text] [Related]

  • 14. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D, Jeannin JF, Martin F.
    C R Seances Acad Sci III; 1982 Nov 08; 295(8):485-8. PubMed ID: 6819063
    [Abstract] [Full Text] [Related]

  • 15. Defective vaccine-induced resistance to Schistosoma mansoni in P strain mice. III. Specificity of the associated defect in cell-mediated immunity.
    James SL, Deblois LA, Al-Zamel F, Glaven J, Langhorne J.
    J Immunol; 1986 Dec 15; 137(12):3959-67. PubMed ID: 3097138
    [Abstract] [Full Text] [Related]

  • 16. Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice.
    Van Nassauw L, Toovey S, Van Op den Bosch J, Timmermans JP, Vercruysse J.
    Travel Med Infect Dis; 2008 Sep 15; 6(5):253-8. PubMed ID: 18760248
    [Abstract] [Full Text] [Related]

  • 17. Preactivation of macrophages in mice acutely infected with Schistosoma mansoni.
    Esparza I, Ruppel A, Mestan J, Krammer PH.
    Immunobiology; 1988 May 15; 177(2):105-19. PubMed ID: 3136079
    [Abstract] [Full Text] [Related]

  • 18. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni.
    King CL, Xianli J, Malhotra I, Liu S, Mahmoud AA, Oettgen HC.
    J Immunol; 1997 Jan 01; 158(1):294-300. PubMed ID: 8977202
    [Abstract] [Full Text] [Related]

  • 19. Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model.
    Keiser J, El Ela NA, El Komy E, El Lakkany N, Diab T, Chollet J, Utzinger J, Barakat R.
    Am J Trop Med Hyg; 2006 Aug 01; 75(2):287-91. PubMed ID: 16896134
    [Abstract] [Full Text] [Related]

  • 20. The host-parasite relationship between the Saudi Arabian Schistosoma mansoni and its intermediate and definitive hosts. 2. Effects of temperature, salinity and pH on the infection of mice by S. mansoni cercariae.
    Lwambo NJ, Upatham ES, Kruatrachue M, Viyanant V.
    Southeast Asian J Trop Med Public Health; 1987 Jun 01; 18(2):166-70. PubMed ID: 3118481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.